ArticleEClinicalMedicine2022

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study.

Javier García-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.